Anticancer effects of bioactive berry compounds
- 5 September 2013
- journal article
- research article
- Published by Springer Nature in Phytochemistry Reviews
- Vol. 13 (1) , 295-322
Abstract
No abstract availableKeywords
This publication has 139 references indexed in Scilit:
- Biological Significance of Urolithins, the Gut Microbial Ellagic Acid-Derived Metabolites: The Evidence So FarEvidence-Based Complementary and Alternative Medicine, 2013
- Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticalsCancer and Metastasis Reviews, 2010
- Myricetin suppresses UVB-induced wrinkle formation and MMP-9 expression by inhibiting RafBiochemical Pharmacology, 2010
- Multiple Berry Types Prevent N-nitrosomethylbenzylamine-Induced Esophageal Cancer in RatsPharmaceutical Research, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Cancer Chemoprevention by Pomegranate: Laboratory and Clinical EvidenceNutrition and Cancer, 2009
- Anthocyanins and their role in cancer preventionCancer Letters, 2008
- Cranberry and blueberry: Evidence for protective effects against cancer and vascular diseasesMolecular Nutrition & Food Research, 2007
- Inhibitory Effect on Activator Protein-1, Nuclear Factor-KappaB, and Cell Transformation by Extracts of Strawberries (Fragaria × ananassa Duch.)Journal of Agricultural and Food Chemistry, 2005
- Anthocyanin‐ and hydrolyzable tannin‐rich pomegranate fruit extract modulates MAPK and NF‐κB pathways and inhibits skin tumorigenesis in CD‐1 miceInternational Journal of Cancer, 2004